Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenoten for children in specific developmental disorders of scholastic skills
NCT03159104Phase 3Completed
- Sponsor
- Materia Medica Holding
- Start
- Aug 2015
- Primary completion
- Feb 2019
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of Tenoten in Specific developmental disorder of scholastic skills (SDDSS), sponsored by Materia Medica Holding. Started Aug 2015; status: completed.
02
Drugs
Tenoten
03
Conditions
Specific developmental disorder of scholastic skills (SDDSS)
Beyond the preview
Go deeper on NCT03159104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03159104.